Funding for this research was provided by:
National Natural Science Foundation of China (81672863, 81872434)
Received: 10 March 2022
Accepted: 1 June 2022
First Online: 14 June 2022
: This retrospective study was performed in accordance with the Declaration of Helsinki and approved to waive informed patient consent by the institutional review board of Sun Yat-sen University Cancer Center (approval number: B2020-330–1) due to the observational and noninterventional study, and the patient’s data were kept under strict control. All experimental protocols in this study were approved by institutional review board of Sun Yat-sen University Cancer Center (approval number: B2020-330–1). The authenticity of this article has been validated by uploading the key raw data onto the Research Data Deposit public platform (ExternalRef removed), with the approval RDD number as RDDA2021001979.
: Not applicable.
: There are no conflicts of financial interest in this study.